Literature DB >> 11082790

Adipose tissue as an endocrine organ? A review of some recent data.

E Faloia1, M A Camilloni, G Giacchetti, F Mantero.   

Abstract

Recent clinical and experimental data have radically modified the concept of adipose tissue as one solely devoted to energy storage and release. Adipose tissue is a target organ for glucocorticoids. Several studies of the function of the hypothalamic-pituitary-adrenal axis in obese subjects have failed to reach conclusive results. An innovative finding is that adipose tissue produces cortisol from its inactive precursor, cortisone. Identification of leptin, a hormone synthesised by adipose tissue, has ushered in the modern view that it is a true endocrine organ. Leptin is produced by subcutaneous and to a lesser extent by visceral adipose tissue. It has a central role in body weight and especially fat stores regulation, but is also involved in several complex functions, including the physiological processes associated with puberty. Angiotensinogen (AGT), another hormone synthesised in abundance by adipose tissue, is produced in larger amounts by visceral than subcutaneous fat. In addition, in man and animals adipose tissue appears to possess the whole renin-angiotensin system (RAS), suggesting that angiotensin II, the final effector of the system, is locally produced. The function of adipose RAS is not well known; besides participating, together with other hormones and substances, in adipocyte differentiation and fat tissue growth, it could be involved in the pathogenesis of the complications of obesity. All these findings have opened interesting prospects and are expected to yield further stimulating insights into the physiopathology of the adipose organ.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11082790     DOI: 10.1007/BF03354441

Source DB:  PubMed          Journal:  Eat Weight Disord        ISSN: 1124-4909            Impact factor:   4.652


  38 in total

1.  Co-expression of renin-angiotensin system genes in human adipose tissue.

Authors:  S Engeli; K Gorzelniak; R Kreutz; N Runkel; A Distler; A M Sharma
Journal:  J Hypertens       Date:  1999-04       Impact factor: 4.844

2.  Depot- and sex-specific differences in human leptin mRNA expression: implications for the control of regional fat distribution.

Authors:  C T Montague; J B Prins; L Sanders; J E Digby; S O'Rahilly
Journal:  Diabetes       Date:  1997-03       Impact factor: 9.461

3.  A longitudinal assessment of hormonal and physical alterations during normal puberty in boys. V. Rising leptin levels may signal the onset of puberty.

Authors:  C S Mantzoros; J S Flier; A D Rogol
Journal:  J Clin Endocrinol Metab       Date:  1997-04       Impact factor: 5.958

4.  Cross-talk between the insulin and angiotensin signaling systems.

Authors:  L A Velloso; F Folli; X J Sun; M F White; M J Saad; C R Kahn
Journal:  Proc Natl Acad Sci U S A       Date:  1996-10-29       Impact factor: 11.205

5.  Glucocorticoids as counterregulatory hormones of leptin: toward an understanding of leptin resistance.

Authors:  K E Zakrzewska; I Cusin; A Sainsbury; F Rohner-Jeanrenaud; B Jeanrenaud
Journal:  Diabetes       Date:  1997-04       Impact factor: 9.461

6.  Leptin and corticosterone have opposite effects on food intake and the expression of UCP1 mRNA in brown adipose tissue of lep(ob)/lep(ob) mice.

Authors:  K Arvaniti; D Ricquier; O Champigny; D Richard
Journal:  Endocrinology       Date:  1998-09       Impact factor: 4.736

7.  The hypothalamic-pituitary-adrenal axis in obese women with different patterns of body fat distribution.

Authors:  R Pasquali; S Cantobelli; F Casimirri; M Capelli; L Bortoluzzi; R Flamia; A M Labate; L Barbara
Journal:  J Clin Endocrinol Metab       Date:  1993-08       Impact factor: 5.958

8.  The role of glucocorticoid activity in the inheritance of hypertension: studies in the rat.

Authors:  C J Kenyon; M Panarelli; C D Holloway; D Dunlop; J J Morton; J M Connell; R Fraser
Journal:  J Steroid Biochem Mol Biol       Date:  1993-04       Impact factor: 4.292

9.  Positional cloning of the mouse obese gene and its human homologue.

Authors:  Y Zhang; R Proenca; M Maffei; M Barone; L Leopold; J M Friedman
Journal:  Nature       Date:  1994-12-01       Impact factor: 49.962

10.  Location and regulation of rat angiotensinogen messenger RNA.

Authors:  L A Cassis; J Saye; M J Peach
Journal:  Hypertension       Date:  1988-06       Impact factor: 10.190

View more
  3 in total

Review 1.  The role of obesity in kidney disease: recent findings and potential mechanisms.

Authors:  Rigas G Kalaitzidis; Kostas C Siamopoulos
Journal:  Int Urol Nephrol       Date:  2011-05-05       Impact factor: 2.370

2.  Blood pressure control and weight loss in overweight or obese patients with previously treated or untreated mild to moderate hypertension given valsartan: An open-label study comparing pretreatment and posttreatment values.

Authors:  Aldo S Villecco; Cinzia Cocci; Maurizio Di Emidio
Journal:  Curr Ther Res Clin Exp       Date:  2004-03

3.  An association between angiotensin II type 2 receptor gene A/C3123 polymorphism and glycemic control marker in a general Japanese population.

Authors:  Kazuhiko Kotani; Shinji Fujiwara; Kokoro Tsuzaki; Yoshiko Sano; Yukiyo Matsuoka; Taku Hamada; Naoki Sakane
Journal:  Mol Biol Rep       Date:  2008-04-25       Impact factor: 2.316

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.